Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,932.93
(
0.68%
)
US TECH 100
24,935.60
(
0.97%
)
Dow Jones
48,403.69
(
0.38%
)
Brent Oil
93.22
(
-2.36%
)
Bitcoin
75,222.59
(
0.97%
)
News Focus
News Focus
Post# of 10282
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Bruinfan4ever

Send PM Follow Ignore
Followers 71
Posts 10390
Boards Moderated 0
Alias Born 01/04/2007

Bruinfan4ever

Re: GE_Jim post# 4738

Friday, 04/02/2021 11:26:37 AM

Friday, April 02, 2021 11:26:37 AM

Post# of 10282
The current timeline is in the investor deck for 18-MC. They expect the phase 3 trial to start at the end of 2023 and be finished by the end of 2024. Now obviously there could be delays and take longer or there could be breakthrough therapy designation and get done faster.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent DFTX News
More DFTX News